Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Family Medicine
Metastatic Cancer Clinical Trials
A listing of Metastatic Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Anniston : Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mobile : Providence Cancer Center at Providence Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Alaska
Anchorage : Providence Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fairbanks : Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Arizona
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Tucson : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Arkansas
Jonesboro : NEA Medical Clinic - East Matthews
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Little Rock : Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
California
Duarte : City of Hope
A Phase 1 Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Subjects with Advanced Solid Tumors
View More »
Castro Valley : East Bay Radiation Oncology Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Castro Valley : Valley Medical Oncology Consultants - Castro Valley
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Concord : Cancer Care Center at John Muir Health - Concord Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Duarte : Research Site
Open Label Extension Study of Conatumumab and AMG 479
Duarte : City of Hope Comprehensive Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fairfield : North Bay Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fremont : Valley Medical Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Grass Valley : Sierra Nevada Cancer Center at Sierra Nevada Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenbrae : Marin Cancer Care
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Long Beach : Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Los Angeles : Samuel Oschin Comprehensive Cancer Institute
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Los Angeles : USC/Norris Comprehensive Cancer Center and Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Martinez : Contra Costa Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Marysville : Tibotec Therapeutics - Division of Ortho Biotech Products, LP
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Merced : Mercy Cancer Center at Mercy Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mountain View : El Camino Hospital Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oakland : Alta Bates Summit Medical Center - Summit Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oakland : CCOP - Bay Area Tumor Institute
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oakland : Epic Care - Oakland
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oakland : Larry G Strieff MD Medical Corporation
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oakland : Tom K Lee, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oakland : Bay Area Breast Surgeons, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oakland : Highland General Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Orange : St. Joseph Hospital Regional Cancer Center - Orange
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Pleasanton : Valley Medical Oncology Consultants - Pleasanton
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sacramento : University of California Davis Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
San Pablo : Doctors Medical Center - San Pablo Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3007113 in Patients With Advanced Cancer
Truckee : Tahoe Forest Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Walnut Creek : John Muir/Mt. Diablo Comprehensive Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Colorado
Aurora : Aurora Presbyterian Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Boulder : Boulder Community Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Colorado Springs : Penrose Cancer Center at Penrose Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Colorado Springs : Memorial Hospital Cancer Center - Colorado Springs
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Denver : Research Site
Open Label Extension Study of Conatumumab and AMG 479
View More »
Denver : Porter Adventist Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Denver : St. Joseph Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Denver : CCOP - Colorado Cancer Research Program
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Denver : Presbyterian - St. Luke's Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Denver : Rose Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Denver : St. Anthony Central Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Englewood : Swedish Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fort Collins : Poudre Valley Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fort Collins : Front Range Cancer Specialists
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Grand Junction : St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greeley : North Colorado Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Littleton : Littleton Adventist Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lone Tree : Sky Ridge Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Longmont : Hope Cancer Care Center at Longmont United Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Loveland : McKee Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Parker : Parker Adventist Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Pueblo : St. Mary - Corwin Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Thornton : North Suburban Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wheat Ridge : Exempla Lutheran Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Connecticut
Delaware
Lewes : Tunnell Cancer Center at Beebe Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Newark : CCOP - Christiana Care Health Services
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Florida
Fort Lauderdale : Holy Cross Hospital
14T-MC-JVBB
View More »
Fort Lauderdale : Broward General Medical Center Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fort Meyers : Florida Cancer Specialists
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Pensacola : Sacred Heart Cancer Center at Sacred Heart Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Pensacola : Sacred Heart Medical Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tampa : Research Site
Open Label Extension Study of Conatumumab and AMG 479
Tampa : H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Titusville : Space Coast Medical Associates
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Georgia
Savannah : Memorial University Medical Center
SWOG S1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
View More »
Atlanta : Northside Hospital Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Atlanta : CCOP - Atlanta Regional
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Atlanta : Piedmont Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Atlanta : Saint Joseph's Hospital of Atlanta
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Austell : WellStar Cobb Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Columbus : John B. Amos Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Decatur : Charles B. Eberhart Cancer Center at DeKalb Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fayetteville : Piedmont Fayette Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Gainesville : Northeast Georgia Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lawrenceville : Gwinnett Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Marietta : Kennestone Cancer Center at Wellstar Kennestone Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Riverdale : Southern Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Rome : Harbin Clinic Cancer Center - Medical Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Savannah : Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Valdosta : Pearlman Comprehensive Cancer Center at South Georgia Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Hawaii
Aiea : Kapiolani Medical Center at Pali Momi
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Honolulu : Kapiolani Medical Center for Women and Children
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Honolulu : OnCare Hawaii, Incorporated - Kuakini
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Honolulu : OnCare Hawaii, Incorporated - Lusitana
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Honolulu : Cancer Research Center of Hawaii
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Honolulu : Hawaii Medical Center - East
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Honolulu : Queen's Cancer Institute at Queen's Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Honolulu : Straub Clinic and Hospital, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Honolulu : Tripler Army Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lihue : Kauai Medical Clinic
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wailuku : Pacific Cancer Institute - Maui
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wailuku : Maui Memorial Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Idaho
Boise : Mountain States Tumor Institute at St. Luke's Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Boise : Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fruitland : Saint Luke's Mountain States Tumor Institute - Fruitland
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lewiston : St. Joseph Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Meridian : Mountain States Tumor Institute - Meridian
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Nampa : Saint Luke's Mountain States Tumor Institute
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Twin Falls : Mountain States Tumor Institute at St. Luke's
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Illinois
Elgin : Sherman Health
SWOG S1201 Phase II Randomized, Pilot Study of FOLFOX Therapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil Versus Irinotecan Hydrochloride and Docetaxel in Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
View More »
Aurora : Rush-Copley Cancer Care Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Carbondale : Memorial Hospital of Carbondale
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Chicago : John H. Stroger, Jr. Hospital of Cook County
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Chicago : Louis A. Weiss Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Decatur : Decatur Memorial Hospital Cancer Care Institute
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Elgin : Sherman Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Evanston : Evanston Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Geneva : Delnor Hospital - Geneva
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Hines : Veterans Affairs Medical Center - Hines
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Maywood : Cardinal Bernardin Cancer Center at Loyola University Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Moline : Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Moline :
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mount Vernon : Good Samaritan Regional Health Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
River Forest : West Suburban Center for Cancer Care
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Springfield : Regional Cancer Center at Memorial Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Urbana : CCOP - Carle Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Warrenville : Central Dupage Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Indiana
Beech Grove : St. Francis Hospital and Health Centers - Beech Grove Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Elkhart : Elkhart Clinic, LLC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Elkhart : Elkhart General Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Elkhart : Michiana Hematology-Oncology, PC - Elkhart
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kokomo : Howard Community Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
La Porte : Center for Cancer Therapy at LaPorte Hospital and Health Services
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Michigan City : Saint Anthony Memorial Health Centers
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mishawaka : Michiana Hematology-Oncology, PC - South Bend
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mishawaka : Saint Joseph Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Plymouth : Michiana Hematology Oncology PC - Plymouth
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Richmond : Reid Hospital & Health Care Services
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
South Bend : CCOP - Northern Indiana CR Consortium
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
South Bend : Memorial Hospital of South Bend
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Westville : Michiana Hematology Oncology PC - La Porte
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Iowa
Ames : McFarland Clinic, PC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Bettendorf :
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Cedar Rapids : Mercy Regional Cancer Center at Mercy Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Cedar Rapids : Cedar Rapids Oncology Associates
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Clive : Medical Oncology and Hematology Associates - West Des Moines
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Davenport : Genesis Regional Cancer Center at Genesis Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Des Moines : John Stoddard Cancer Center at Iowa Lutheran Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Des Moines : Medical Oncology and Hematology Associates at Mercy Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Des Moines : CCOP - Iowa Oncology Research Association
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Des Moines : John Stoddard Cancer Center at Iowa Methodist Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Des Moines : Medical Oncology and Hematology Associates at John Stoddard Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Des Moines : Mercy Cancer Center at Mercy Medical Center - Des Moines
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mason City : Mercy Cancer Center at Mercy Medical Center - North Iowa
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sioux City : Mercy Medical Center - Sioux City
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sioux City : Siouxland Hematology-Oncology Associates, LLP
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sioux City : St. Luke's Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kansas
Chanute : Cancer Center of Kansas, PA - Chanute
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dodge City : Cancer Center of Kansas, PA - Dodge City
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
El Dorado : Cancer Center of Kansas, PA - El Dorado
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fort Scott : Cancer Center of Kansas - Fort Scott
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Independence : Cancer Center of Kansas-Independence
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Kingman : Cancer Center of Kansas, PA - Kingman
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lawrence : Lawrence Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Liberal : Cancer Center of Kansas, PA - Liberal
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
McPherson : Cancer Center of Kansas, PA - McPherson
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Newton : Cancer Center of Kansas, PA - Newton
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Overland Park : Menorah Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Overland Park : Saint Luke's Hospital - South
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Parsons : Cancer Center of Kansas, PA - Parsons
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Prairie Village : CCOP - Kansas City
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Pratt : Cancer Center of Kansas, PA - Pratt
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Salina : Cancer Center of Kansas, PA - Salina
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Salina : Tammy Walker Cancer Center at Salina Regional Health Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Topeka : Cotton-O'Neil Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wellington : Cancer Center of Kansas, PA - Wellington
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wichita : Associates in Womens Health, PA - North Review
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wichita : Cancer Center of Kansas, PA - Medical Arts Tower
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wichita : Cancer Center of Kansas, PA - Wichita
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wichita : CCOP - Wichita
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wichita : Via Christi Cancer Center at Via Christi Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Winfield : Cancer Center of Kansas, PA - Winfield
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Louisiana
Baton Rouge : Ochsner Health Center - Bluebonnet
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Covington : Ochsner Health Center - Covington
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Monroe : Louisiana State University Health Sciences Center - Monroe
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
New Orleans : CCOP - Ochsner
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
New Orleans : Ochsner Cancer Institute at Ochsner Clinic Foundation
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Shreveport : Highland Clinic
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Shreveport : Feist-Weiller Cancer Center at Louisiana State University Health Sciences
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Maryland
Elkton MD : Union Hospital of Cecil County
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Massachusetts
Methuen : Caritas Holy Family Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Michigan
Adrian : Hickman Cancer Center at Bixby Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Ann Arbor : CCOP - Michigan Cancer Research Consortium
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Ann Arbor : Saint Joseph Mercy Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Ann Arbor : University of Michigan Comprehensive Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Battle Creek : Battle Creek Health System Cancer Care Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Bay City : Bay Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Big Rapids : Mecosta County Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dearborn : Oakwood Cancer Center at Oakwood Hospital and Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Detriot : Karmanos Cancer Institute
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Detroit : Josephine Ford Cancer Center at Henry Ford Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Escanaba : Green Bay Oncology, Limited - Escanaba
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Flint : Genesys Hurley Cancer Institute
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Flint : Hurley Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Flint : Singh and Arora Hematology Oncology, PC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Flint : McLaren Cancer Institute
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Grand Rapids : Butterworth Hospital at Spectrum Health
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Grand Rapids : CCOP - Grand Rapids
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Grand Rapids : Lacks Cancer Center at Saint Mary's Health Care
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Grosse Pointe Woods : Van Elslander Cancer Center at St. John Hospital and Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Iron Mountain : Dickinson County Healthcare System
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Jackson : Foote Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kalamazoo : Borgess Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kalamazoo : Bronson Methodist Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kalamazoo : West Michigan Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lansing : Breslin Cancer Center at Ingham Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lansing : Sparrow Regional Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lapeer : Great Lakes Cancer Institute - Lapeer Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Livonia : St. Mary Mercy Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Monroe : Community Cancer Center of Monroe
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Monroe : Mercy Memorial Hospital - Monroe
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mount Clemens : Clemens Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Muskegon : Mercy General Health Partners
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Petoskey : Northern Michigan Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Pontiac : St. Joseph Mercy Oakland
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Port Huron : Mercy Regional Cancer Center at Mercy Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Reed City : Spectrum Health Reed City Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Royal Oak : William Beaumont Hospital - Royal Oak Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saginaw : Seton Cancer Institute at Saint Mary's - Saginaw
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Joseph : Lakeside Cancer Specialists, PLLC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Joseph : Lakeland Regional Cancer Care Center - St. Joseph
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Southfield : Providence Cancer Institute at Providence Hospital - Southfield Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Traverse City : Munson Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Warren : St. John Macomb Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Minnesota
Brainerd : St. Joseph's Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Burnsville : Fairview Ridges Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Coon Rapids : Mercy and Unity Cancer Center at Mercy Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Duluth : Miller - Dwan Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Duluth : CCOP - Duluth
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Duluth : Duluth Clinic Cancer Center - Duluth
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Edina : Fairview Southdale Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Fridley : Mercy and Unity Cancer Center at Unity Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Hutchinson : Hutchinson Area Health Care
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Maplewood : HealthEast Cancer Care at St. John's Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Maplewood : Minnesota Oncology - Maplewood
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Minneapolis : Hennepin County Medical Center - Minneapolis
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Minneapolis : Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
New Ulm : New Ulm Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Robbinsdale : Humphrey Cancer Center at North Memorial Outpatient Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis Park : CCOP - Metro-Minnesota
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis Park : Park Nicollet Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Paul : United Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Shakopee : St. Francis Cancer Center at St. Francis Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
St. Paul : Regions Hospital Cancer Care Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Stillwater : Lakeview Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Waconia : Ridgeview Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Willmar : Willmar Cancer Center at Rice Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Woodbury : Minnesota Oncology - Woodbury
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mississippi
Jackson : Veterans Affairs Medical Center - Jackson
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Jackson : University of Mississippi Cancer Clinic
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Pascagoula : Regional Cancer Center at Singing River Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Missouri
Cape Girardeau : Southeast Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Cape Girardeau : Saint Francis Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Jefferson City : Goldschmidt Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kansas City : Heartland Hematology Oncology Associates, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kansas City : North Kansas City Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Kansas City : Research Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kansas City : Saint Luke's Cancer Institute at Saint Luke's Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kansas City : Veterans Affairs Medical Center - Kansas City
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lee's Summit : Saint Luke's East - Lee's Summit
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Liberty : Parvin Radiation Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Joseph : Heartland Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Joseph : Saint Joseph Oncology, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis : David C. Pratt Cancer Center at St. John's Mercy
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis : Saint Louis University Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis : CCOP - St. Louis-Cape Girardeau
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis : Christian Hospital Northeast Cancer Care Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis : Midwest Hematology Oncology Group, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint Louis : Missouri Baptist Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Montana
Billings : Billings Clinic - Downtown
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Billings : CCOP - Montana Cancer Consortium
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Billings : Hematology-Oncology Centers of the Northern Rockies - Billings
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Billings : St. Vincent Healthcare Cancer Care Services
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Bozeman : Bozeman Deaconess Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Butte : St. James Healthcare Cancer Care
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Great Falls : Big Sky Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Great Falls : Sletten Cancer Institute at Benefis Healthcare
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Helena : St. Peter's Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kalispell : Kalispell Medical Oncology at KRMC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kalispell : Kalispell Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Missoula : Montana Cancer Specialists at Montana Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Missoula : Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Nebraska
Kearney : Good Samaritan Cancer Center at Good Samaritan Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lincoln : Cancer Resource Center - Lincoln
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Omaha : CCOP - Missouri Valley Cancer Consortium
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Omaha : Creighton University Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Omaha : Lakeside Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Omaha : Alegant Health Cancer Center at Bergan Mercy Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Omaha : Immanuel Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Nevada
Las Vegas : Nevada Cancer Institute
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Las Vegas : University Medical Center of Southern Nevada
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Las Vegas : CCOP - Nevada Cancer Research Foundation
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
New Hampshire
Lebanon : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New Jersey
Newark : UMDNJ University Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Voorhees : Cancer Institute of New Jersey at Cooper - Voorhees
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
New Mexico
Albuquerque : Hematology Oncology Associates, PC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Albuquerque : University of New Mexico Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
New York
Manhasset : Biomedical Research Alliance of New York
Metastatic Cancer to the Brain - Adults
View More »
Buffalo : Research Site
Open Label Extension Study of Conatumumab and AMG 479
East Syracuse : CCOP - Hematology-Oncology Associates of Central New York
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Elmira : Falck Cancer Center at Arnot Ogden Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Great Neck : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Rochester : James P. Wilmot Cancer Center at University of Rochester Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
North Carolina
Asheville : Mission Hospitals - Memorial Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Charlotte : Presbyterian Cancer Center at Presbyterian Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Goldsboro : Wayne Memorial Hospital, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Hendersonville : Pardee Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Huntersville : Carolina BioOncology Institute
Isolation and Culture of Circulating Tumor Cells From Peripheral Blood
View More »
Pinehurst : FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Rutherfordton : Rutherford Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Statesville : Iredell Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Winston-Salem : Forsyth Regional Cancer Center at Forsyth Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
North Dakota
Bismarck : St. Alexius Medical Center
A research study for patients with metastatic pancreatic cancer. You may qualify for this study if you have a diagnosis of an advanced type of pancreatic cancer for which standard therapy is not optimal.
Ohio
Akron : McDowell Cancer Center at Akron General Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Bowling Green : Wood County Oncology Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Chillicothe : Adena Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Cincinnati : Charles M. Barrett Cancer Center at University Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Columbus : CCOP - Columbus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Columbus : Doctors Hospital at Ohio Health
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Columbus : Grant Medical Center Cancer Care
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Columbus : Mount Carmel Health - West Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Columbus : Riverside Methodist Hospital Cancer Care
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dayton : CCOP - Dayton
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dayton : David L. Rike Cancer Center at Miami Valley Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dayton : Good Samaritan Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dayton : Grandview Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dayton : Samaritan North Cancer Care Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Delaware : Grady Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Elyria : Hematology Oncology Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Elyria : Community Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Findlay : Blanchard Valley Medical Associates
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Franklin : Middletown Regional Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenville : Wayne Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kettering : Charles F. Kettering Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lancaster : Fairfield Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Lima : Lima Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Marietta : Strecker Cancer Center at Marietta Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Maumee : Northwest Ohio Oncology Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Middletown : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Mount Vernon : Knox Community Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Newark : Licking Memorial Cancer Care Program at Licking Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oregon : St. Charles Mercy Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oregon : Toledo Clinic - Oregon
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Portsmouth : Southern Ohio Medical Center Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Springfield : Community Hospital of Springfield and Clark County
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sylvania : Flower Hospital Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tiffin : Mercy Hospital of Tiffin
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Toledo : CCOP - Toledo Community Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Toledo : Toledo Clinic, Incorporated - Main Clinic
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Toledo : Medical University of Ohio Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Toledo : St. Anne Mercy Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Toledo : St. Vincent Mercy Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Toledo : Toledo Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Troy : UVMC Cancer Care Center at Upper Valley Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wauseon : Fulton County Health Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Westerville : Mount Carmel St. Ann's Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wright-Patterson Afb : United States Air Force Medical Center - Wright-Patterson
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Xenia : Ruth G. McMillan Cancer Center at Greene Memorial Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Zanesville : Genesis - Good Samaritan Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oklahoma
Oregon
Clackamas : Clackamas Radiation Oncology Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Coos Bay : Bay Area Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Grants Pass : Three Rivers Community Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Gresham : Legacy Mount Hood Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Medford : Dubs Cancer Center at Rogue Valley Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Medford : Providence Cancer Center at PMCC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Milwaukie : Providence Milwaukie Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Newberg : Providence Newberg Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oregon City : Willamette Falls Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Portland : CCOP - Columbia River Oncology Program
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Portland : Providence Cancer Center at Providence Portland Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Portland : Providence St. Vincent Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Portland : Legacy Good Samaritan Hospital & Comprehensive Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tualatin : Legacy Meridian Park Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Pennsylvania
Allentown : Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Philadelphia : Albert Einstein Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
South Carolina
Anderson : AnMed Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Charleston : Hollings Cancer Center at Medical University of South Carolina
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Easley : Cancer Centers of the Carolinas - Easley
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenville : Bon Secours St. Francis Health System
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenville : Cancer Centers of the Carolinas - Eastside
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Greenville : Cancer Centers of the Carolinas - Faris Road
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenville : Cancer Centers of the Carolinas - Grove Commons
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenville : CCOP - Greenville
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenville : Greenville Hospital Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greenwood : Self Regional Cancer Center at Self Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greer : Cancer Centers of the Carolinas - Greer Medical Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Greer : Cancer Centers of the Carolinas - Greer Radiation Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seneca : Cancer Centers of the Carolinas - Seneca
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Spartanburg : Cancer Centers of the Carolinas - Spartanburg
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Spartanburg : CCOP - Upstate Carolina
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Spartanburg : Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
South Dakota
Sioux Falls : Sanford Cancer Center at Sanford USD Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tennessee
Texas
Amarillo : Harrington Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Dallas : Mary Crowley Cancer Research Centers
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Fort Sam Houston : Brooke Army Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Galveston : University of Texas Medical Branch
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Houston : Research Site
Open Label Extension Study of Conatumumab and AMG 479
View More »
Houston : Ben Taub General Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Houston : Baylor University Medical Center - Houston
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Houston : M. D. Anderson Cancer Center at University of Texas
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Houston : St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Houston : Veterans Affairs Medical Center - Houston
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3007113 in Patients With Advanced Cancer
San Antonio : University Hospital - San Antonio
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
San Antonio : University of Texas Health Science Center at San Antonio
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
San Antonio : Veterans Affairs Medical Center - San Antonio (Murphy)
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
San Antonio : Cancer Therapy and Research Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Temple : CCOP - Scott and White Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Utah
American Fork : American Fork Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Cedar City : Sandra L. Maxwell Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Logan : Logan Regional Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Murray : Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Ogden : Research Site
Open Label Extension Study of Conatumumab and AMG 479
View More »
Ogden : Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Provo : Utah Valley Regional Medical Center - Provo
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Saint George : Dixie Regional Medical Center - East Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Salt Lake City : LDS Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Salt Lake City : Huntsman Cancer Institute at University of Utah
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Salt Lake City : Utah Cancer Specialists at UCS Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Virginia
Fredericksburg : Fredericksburg Oncology, Incorporated
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Washington
Anacortes : Island Hospital Cancer Care Center at Island Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Bellingham : St. Joseph Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Bremerton : Olympic Hematology and Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Burien : Highline Medical Center Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Centralia : Providence Centralia Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Everett : Providence Regional Cancer Partnership
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Federal Way : St. Francis Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Issaquah : Swedish Medical Center - Issaquah Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kennewick : Columbia Basin Hematology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Kirkland : Cascade Cancer Center at Evergreen Hospital Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Mount Vernon : Skagit Valley Hospital Cancer Care Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Olympia : Providence St. Peter Hospital Regional Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Poulsbo : Harrison Poulsbo Hematology and Onocology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Puyallup : Good Samaritan Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : CCOP - Virginia Mason Research Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Fred Hutchinson Cancer Research Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Group Health Central Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Harborview Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Minor and James Medical, PLLC
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Pacific Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Polyclinic First Hill
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : University Cancer Center at University of Washington Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Seattle : Virginia Mason Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sedro-Woolley : North Puget Oncology at United General Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Spokane : Cancer Care Northwest - Spokane South
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Spokane : Evergreen Hematology and Oncology, PS
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tacoma : Allenmore Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tacoma : CCOP - Northwest
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tacoma : St. Clare Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tacoma : Franciscan Cancer Center at St. Joseph Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Tacoma : MultiCare Regional Cancer Center at Tacoma General Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Vancouver : Legacy Salmon Creek Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Vancouver : Southwest Washington Medical Center Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wenatchee : Wenatchee Valley Medical Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wisconsin
Green Bay : Green Bay Oncology, Limited at St. Mary's Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Green Bay : St. Mary's Hospital Medical Center - Green Bay
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Green Bay : Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Green Bay : St. Vincent Hospital Regional Cancer Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
La Crosse : Gundersen Lutheran Center for Cancer and Blood
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
View More »
Manitowoc : Holy Family Memorial Medical Center Cancer Care Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Oconto Falls : Green Bay Oncology, Limited - Oconto Falls
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sheboygan : St. Nicholas Hospital
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Sturgeon Bay : Green Bay Oncology, Limited - Sturgeon Bay
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Wyoming
Casper : Rocky Mountain Oncology
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Belgium
Leuven : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Liege : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Wilrijk : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
France
Bordeaux : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Caen Cedex 05 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
La Roche Sur Yon Cedex 9 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Marseille : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Nantes Cedex 2 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
View More »
Pierre Bénite Cedex : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Toulouse : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Korea, Republic of
Seoul : Samsung Medical Center
Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer
Mexico
Tlalpan : Instituto Nacional de Cancerologia
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Poland
Szczecin : Research Site
Open Label Extension Study of Conatumumab and AMG 479
Saudi Arabia
Riyadh : King Faisal Specialist Hospital and Research Center
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Spain
Barcelona : Research Site
Open Label Extension Study of Conatumumab and AMG 479
Barcelona : Research Site
Open Label Extension Study of Conatumumab and AMG 479
